Mylan launches generic version of Prandin
PITTSBURGH — Mylan on Thursday announced that its subsidiary has launched repaglinide tablets, a generic version of Novo Nordisk’s Prandin. The drug is used to improve glycemic control in adults with Type 2 diabetes mellitus.
Repaglinide tablets in 0.5 mg, 1 mg and 2 mg had sales in the United States of approximately $212.95 million for the 12 months ending Sept. 30, 2013, according to IMS Health.
Anoka-Ramsey now offers pharmacy technician degree
CAMBRIDGE, Minn. — Anoka-Ramsey Community College announced that it will offer an associate in science degree in pharmacy technician. The required general education courses for the new program can be taken at either the Cambridge or Coon Rapids locations.
Program-specific courses are held at the Cambridge campus to help meet the needs of area pharmacies, according to the college.
“This is an exciting opportunity for both our students and business partners in the Cambridge area,” Natasha Baer, associate dean of educational services, said. “The addition of this program provides more flexible training options that lead to industry employment in a short amount of time.”
The AAS degree was created as part of a Health Professionals Pathways grant initiative to allow students to obtain credentials to work in the pharmacy field. A student may begin with Anoka-Ramsey’s Pharmacy Technician certificate, which enables the student to work in the industry. The student can then pursue the AAS degree. They also may take additional coursework to prepare for a doctor of pharmacy program.
Applications for the Pharmacy Technician program for fall 2014 semester will be accepted Feb. 1 to Feb. 28.
Avella Specialty Pharmacy recognized as one of 100 ‘Mid-Market Elite’ companies
PHOENIX — Avella Specialty Pharmacy on Thursday was recognized in Chief Executive magazine’s first list of the “Mid-Market Elite.” Avella joins other highly-regarded companies, including Twitter, LinkedIn and LifeLock, in receiving this honor that is given to 100 companies.
The winners were selected based on their strengths in the following key areas: superior growth, a track record of innovation, an exceptional corporate culture, charismatic leadership and a compelling business model. Avella Specialty Pharmacy represented the only pharmacy operator on the list.
“It is exciting to learn that Avella has been recognized as a top performing company,” said Avella president Keith Cook. “We are honored to be included on such a prestigious list and joined by other companies that are driving innovation and excellence.”
Chief Executive magazine worked in partnership with GE Capital and the National Center for the Middle Market (Fisher School of Business) at Ohio State University to select 100 honorees from a pool of more than 197,000 public and private companies. The publication specifically called out Avella as the premier provider in the specialty pharmacy industry.